Peter A. De Bruijn
Dr. Molewaterplein 40
Rotterdam, ZH 3015GD, Netherlands
Rotterdam, ZH 3015GD, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 79 publications
Brief Report: Reducing Lorlatinib-Related Adverse Events by Establishing the Optimal Exposure-Toxicity Threshold in Patients With NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 10, 2026
Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 10, 2026
OATP2B1 Deficiency Ameliorates Irinotecan-Induced Gastrointestinal Toxicity.
Journal: Clinical and translational science
Published: August 15, 2025
A micellar nanoprobe for fluorescence image-guided delineation of glioblastoma margins.
Journal: Pharmacological research
Published: April 15, 2025
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross-over pharmacokinetic drug-drug interaction study.
Journal: Cancer communications (London, England)
Published: November 20, 2024
A Repurposed Drug Selection Pipeline to Identify CNS-Penetrant Drug Candidates for Glioblastoma.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 25, 2024
Systematic Evaluation of Tyrosine Kinase Inhibitors as OATP1B1 Substrates Using a Competitive Counterflow Screen.
Journal: Cancer research communications
Published: June 14, 2024
The OCT2/MATE1 Interaction Between Trifluridine, Metformin and Cimetidine: A Crossover Pharmacokinetic Study.
Journal: Clinical pharmacokinetics
Published: May 30, 2024
Intraperitoneal pharmacokinetics of systemic oxaliplatin, 5-fluorouracil and bevacizumab in patients with colorectal peritoneal metastases.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 29, 2024
Clinical Utility of Circulating Tumor DNA in Patients With Advanced KRASG12C-Mutated NSCLC Treated With Sotorasib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: February 14, 2024
Quantification and clinical validation of the selective MET kinase inhibitor DO-2 and its metabolites DO-5 and M3 in human plasma.
Journal: Journal of pharmaceutical and biomedical analysis
Published: November 21, 2023
Darolutamide does not interfere with OATP-mediated uptake of docetaxel.
Journal: International journal of cancer
Published: November 15, 2023
Last Updated: 09/26/2026